Status:
COMPLETED
NeuroGlove PD Study Clinical
Lead Sponsor:
NeuroGlove LLC
Conditions:
Parkinson Disease
Eligibility:
All Genders
18-85 years
Phase:
EARLY_PHASE1
Brief Summary
Safety and Feasibility of Peripheral Sensory Stimulation of the Hand in the Treatment of Parkinson's Disease
Detailed Description
This is a prospective, homebased, interventional clinical study in which 8 subjects will be enrolled. Eight (8) subjects who suffer from Parkinson's disease will receive treatment using the NeuroGlove...
Eligibility Criteria
Inclusion
- Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
- Men and women ≥18 and \<85 years of age.
- Carry an active diagnosis of PD
- Suffer from PD symptoms that impact subject's daily activities and quality of life
Exclusion
- Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
- Lacks the ability to comprehend or follow instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
- Currently participating in another interventional clinical trial (observational clinical trial participation is allowed for study enrollment.)
Key Trial Info
Start Date :
August 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2024
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06578273
Start Date
August 22 2024
End Date
August 22 2024
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NeuroGlove
Minneapolis, Minnesota, United States, 55416